Nahon, Pierre <br/><br/>
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.  [electronic resource] 

 -  Gastroenterology  01 2017 
 - 142-156.e2 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2016.09.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Aspartate Aminotransferases--blood<br/>Bacterial Infections--epidemiology<br/>Body Mass Index<br/>Carcinoma, Hepatocellular--epidemiology<br/>Cardiovascular Diseases--epidemiology<br/>Diabetes Mellitus--epidemiology<br/>Dyslipidemias--epidemiology<br/>Female<br/>Follow-Up Studies<br/>France--epidemiology<br/>Hepatitis C--complications<br/>Humans<br/>Incidence<br/>Liver Cirrhosis--complications<br/>Liver Neoplasms--epidemiology<br/>Male<br/>Metabolic Syndrome--epidemiology<br/>Middle Aged<br/>Platelet Count<br/>Prospective Studies<br/>Prothrombin Time<br/>Sustained Virologic Response<br/>gamma-Glutamyltransferase--blood